Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Intermediate filaments in cardiomyopathy.

Tsikitis M, Galata Z, Mavroidis M, Psarras S, Capetanaki Y.

Biophys Rev. 2018 Aug;10(4):1007-1031. doi: 10.1007/s12551-018-0443-2. Epub 2018 Jul 19. Review.

2.

Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin.

Hol EM, Capetanaki Y.

Cold Spring Harb Perspect Biol. 2017 Dec 1;9(12). pii: a021642. doi: 10.1101/cshperspect.a021642. Review.

PMID:
29196434
3.

Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy model.

Rapti K, Diokmetzidou A, Kloukina I, Milner DJ, Varela A, Davos CH, Capetanaki Y.

Free Radic Biol Med. 2017 Sep;110:206-218. doi: 10.1016/j.freeradbiomed.2017.06.010. Epub 2017 Jun 16.

PMID:
28629836
4.

Nebulette is a powerful cytolinker organizing desmin and actin in mouse hearts.

Hernandez DA, Bennett CM, Dunina-Barkovskaya L, Wedig T, Capetanaki Y, Herrmann H, Conover GM.

Mol Biol Cell. 2016 Dec 1;27(24):3869-3882. Epub 2016 Oct 12.

5.

Desmin and αB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival.

Diokmetzidou A, Soumaka E, Kloukina I, Tsikitis M, Makridakis M, Varela A, Davos CH, Georgopoulos S, Anesti V, Vlahou A, Capetanaki Y.

J Cell Sci. 2016 Oct 15;129(20):3705-3720. Epub 2016 Aug 26.

6.

Strategies to Study Desmin in Cardiac Muscle and Culture Systems.

Diokmetzidou A, Tsikitis M, Nikouli S, Kloukina I, Tsoupri E, Papathanasiou S, Psarras S, Mavroidis M, Capetanaki Y.

Methods Enzymol. 2016;568:427-59. doi: 10.1016/bs.mie.2015.09.026. Epub 2015 Nov 3.

PMID:
26795479
7.

Desmin enters the nucleus of cardiac stem cells and modulates Nkx2.5 expression by participating in transcription factor complexes that interact with the nkx2.5 gene.

Fuchs C, Gawlas S, Heher P, Nikouli S, Paar H, Ivankovic M, Schultheis M, Klammer J, Gottschamel T, Capetanaki Y, Weitzer G.

Biol Open. 2016 Jan 19;5(2):140-53. doi: 10.1242/bio.014993.

8.

Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18.

Papathanasiou S, Rickelt S, Soriano ME, Schips TG, Maier HJ, Davos CH, Varela A, Kaklamanis L, Mann DL, Capetanaki Y.

Nat Med. 2015 Sep;21(9):1076-84. doi: 10.1038/nm.3925. Epub 2015 Aug 17.

9.

Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy.

Mavroidis M, Davos CH, Psarras S, Varela A, C Athanasiadis N, Katsimpoulas M, Kostavasili I, Maasch C, Vater A, van Tintelen JP, Capetanaki Y.

Basic Res Cardiol. 2015 May;110(3):27. doi: 10.1007/s00395-015-0485-6. Epub 2015 Apr 8.

PMID:
25851234
10.

Desmin related disease: a matter of cell survival failure.

Capetanaki Y, Papathanasiou S, Diokmetzidou A, Vatsellas G, Tsikitis M.

Curr Opin Cell Biol. 2015 Feb;32:113-20. doi: 10.1016/j.ceb.2015.01.004. Epub 2015 Feb 11. Review.

11.

Μyospryn: a multifunctional desmin-associated protein.

Tsoupri E, Capetanaki Y.

Histochem Cell Biol. 2013 Jul;140(1):55-63. doi: 10.1007/s00418-013-1103-z. Epub 2013 Jun 9. Review.

PMID:
23748244
12.

Regulation of adverse remodelling by osteopontin in a genetic heart failure model.

Psarras S, Mavroidis M, Sanoudou D, Davos CH, Xanthou G, Varela AE, Panoutsakopoulou V, Capetanaki Y.

Eur Heart J. 2012 Aug;33(15):1954-63. doi: 10.1093/eurheartj/ehr119. Epub 2011 Apr 26.

PMID:
21525025
13.

Desmin-related myopathy.

van Spaendonck-Zwarts KY, van Hessem L, Jongbloed JD, de Walle HE, Capetanaki Y, van der Kooi AJ, van Langen IM, van den Berg MP, van Tintelen JP.

Clin Genet. 2011 Oct;80(4):354-66. doi: 10.1111/j.1399-0004.2010.01512.x. Epub 2010 Jul 21. Review.

PMID:
20718792
14.

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.

Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, Mavroidis M, Capetanaki Y, Boudoulas H, Kremastinos DT.

Eur J Clin Invest. 2010 Apr;40(4):288-93. doi: 10.1111/j.1365-2362.2010.02257.x.

PMID:
20192976
15.

Plasma levels of osteopontin before and 24 h after percutaneous coronary intervention.

Georgiadou P, Iliodromitis EK, Kolokathis F, Mavroidis M, Andreadou I, Demopoulou M, Varounis Ch, Capetanaki Y, Boudoulas H, Kremastinos DT.

Expert Opin Ther Targets. 2008 Dec;12(12):1477-80. doi: 10.1517/14728220802510740 .

PMID:
19007317
16.

Relationship between plasma osteopontin and oxidative stress in patients with coronary artery disease.

Georgiadou P, Iliodromitis EK, Varounis C, Mavroidis M, Kolokathis F, Andreadou I, Psarras S, Capetanaki Y, Boudoulas H, Kremastinos DT.

Expert Opin Ther Targets. 2008 Aug;12(8):917-20. doi: 10.1517/14728222.12.8.917 .

PMID:
18620515
17.

Altered expression of calreticulin during the development of fibrosis.

Kypreou KP, Kavvadas P, Karamessinis P, Peroulis M, Alberti A, Sideras P, Psarras S, Capetanaki Y, Politis PK, Charonis AS.

Proteomics. 2008 Jun;8(12):2407-19. doi: 10.1002/pmic.200700831.

PMID:
18563736
18.

A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization.

Mavroidis M, Panagopoulou P, Kostavasili I, Weisleder N, Capetanaki Y.

FASEB J. 2008 Sep;22(9):3318-27. doi: 10.1096/fj.07-088724. Epub 2008 Jun 6.

19.

Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure.

Panagopoulou P, Davos CH, Milner DJ, Varela E, Cameron J, Mann DL, Capetanaki Y.

J Cell Biol. 2008 Jun 2;181(5):761-75. doi: 10.1083/jcb.200710049.

20.

Proper perinuclear localization of the TRIM-like protein myospryn requires its binding partner desmin.

Kouloumenta A, Mavroidis M, Capetanaki Y.

J Biol Chem. 2007 Nov 30;282(48):35211-21. Epub 2007 Sep 14.

21.

Muscle intermediate filaments and their links to membranes and membranous organelles.

Capetanaki Y, Bloch RJ, Kouloumenta A, Mavroidis M, Psarras S.

Exp Cell Res. 2007 Jun 10;313(10):2063-76. Epub 2007 Apr 3. Review.

PMID:
17509566
22.

Blood vessels and desmin control the positioning of nuclei in skeletal muscle fibers.

Ralston E, Lu Z, Biscocho N, Soumaka E, Mavroidis M, Prats C, Lømo T, Capetanaki Y, Ploug T.

J Cell Physiol. 2006 Dec;209(3):874-82.

PMID:
16972267
23.

Desmin modulates lung elastic recoil and airway responsiveness.

Shardonofsky FR, Capetanaki Y, Boriek AM.

Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L890-6. Epub 2005 Dec 30.

24.

Desmin cytoskeleton in healthy and failing heart.

Capetanaki Y.

Heart Fail Rev. 2000 Oct;5(3):203-20. Review. No abstract available.

PMID:
16228905
25.

Alterations in the heart mitochondrial proteome in a desmin null heart failure model.

Fountoulakis M, Soumaka E, Rapti K, Mavroidis M, Tsangaris G, Maris A, Weisleder N, Capetanaki Y.

J Mol Cell Cardiol. 2005 Mar;38(3):461-74.

PMID:
15733906
26.

Structural and functional roles of desmin in mouse skeletal muscle during passive deformation.

Shah SB, Davis J, Weisleder N, Kostavassili I, McCulloch AD, Ralston E, Capetanaki Y, Lieber RL.

Biophys J. 2004 May;86(5):2993-3008.

27.

Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement.

Weisleder N, Soumaka E, Abbasi S, Taegtmeyer H, Capetanaki Y.

J Mol Cell Cardiol. 2004 Jan;36(1):121-8.

PMID:
14734054
28.

Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy.

Weisleder N, Taffet GE, Capetanaki Y.

Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):769-74. Epub 2004 Jan 8.

29.

Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates.

Camargo FD, Green R, Capetanaki Y, Jackson KA, Goodell MA.

Nat Med. 2003 Dec;9(12):1520-7. Epub 2003 Nov 16. Erratum in: Nat Med. 2004 Jan;10(1):105. Capetenaki, Yassemi [corrected to Capetanaki, Yassemi].

PMID:
14625546
30.

Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance.

Haubold KW, Allen DL, Capetanaki Y, Leinwand LA.

J Appl Physiol (1985). 2003 Oct;95(4):1617-22. Epub 2003 Jul 3.

31.

Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function.

Capetanaki Y.

Trends Cardiovasc Med. 2002 Nov;12(8):339-48. Review.

PMID:
12536120
32.

Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis.

Chen F, Chang R, Trivedi M, Capetanaki Y, Cryns VL.

J Biol Chem. 2003 Feb 28;278(9):6848-53. Epub 2002 Dec 10.

33.

Costameres: repeating structures at the sarcolemma of skeletal muscle.

Bloch RJ, Capetanaki Y, O'Neill A, Reed P, Williams MW, Resneck WG, Porter NC, Ursitti JA.

Clin Orthop Relat Res. 2002 Oct;(403 Suppl):S203-10. Review.

PMID:
12394470
34.

Sarcolemmal organization in skeletal muscle lacking desmin: evidence for cytokeratins associated with the membrane skeleton at costameres.

O'Neill A, Williams MW, Resneck WG, Milner DJ, Capetanaki Y, Bloch RJ.

Mol Biol Cell. 2002 Jul;13(7):2347-59.

35.

Amino-terminally truncated desmin rescues fusion of des(-/-) myoblasts but negatively affects cardiomyogenesis and smooth muscle development.

Höllrigl A, Puz S, Al-Dubai H, Kim JU, Capetanaki Y, Weitzer G.

FEBS Lett. 2002 Jul 17;523(1-3):229-33.

36.
37.

Evidence for increased myofibrillar mobility in desmin-null mouse skeletal muscle.

Shah SB, Su FC, Jordan K, Milner DJ, Fridén J, Capetanaki Y, Lieber RL.

J Exp Biol. 2002 Feb;205(Pt 3):321-5.

38.

High-throughput site-directed mutagenesis in ES cells.

Höllrigl A, Hergovich A, Görzer I, Bader A, Ellersdorfer G, Habegger K, Hammer E, Enzinger S, Capetanaki Y, Weitzer G.

Biochem Biophys Res Commun. 2001 Nov 30;289(2):329-36.

PMID:
11716476
39.

Paracrine promotion of cardiomyogenesis in embryoid bodies by LIF modulated endoderm.

Bader A, Gruss A, Höllrigl A, Al-Dubai H, Capetanaki Y, Weitzer G.

Differentiation. 2001 Aug;68(1):31-43.

PMID:
11683491
40.

Sarcomere number regulation maintained after immobilization in desmin-null mouse skeletal muscle.

Shah SB, Peters D, Jordan KA, Milner DJ, Fridén J, Capetanaki Y, Lieber RL.

J Exp Biol. 2001 May;204(Pt 10):1703-10.

41.

Paranemin and the organization of desmin filament networks.

Schweitzer SC, Klymkowsky MW, Bellin RM, Robson RM, Capetanaki Y, Evans RM.

J Cell Sci. 2001 Mar;114(Pt 6):1079-89.

42.

Desmin integrates the three-dimensional mechanical properties of muscles.

Boriek AM, Capetanaki Y, Hwang W, Officer T, Badshah M, Rodarte J, Tidball JG.

Am J Physiol Cell Physiol. 2001 Jan;280(1):C46-52.

43.

Desmin knockout muscles generate lower stress and are less vulnerable to injury compared with wild-type muscles.

Sam M, Shah S, Fridén J, Milner DJ, Capetanaki Y, Lieber RL.

Am J Physiol Cell Physiol. 2000 Oct;279(4):C1116-22.

44.

Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function.

Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y.

J Cell Biol. 2000 Sep 18;150(6):1283-98.

45.

The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function.

Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, Capetanaki Y.

J Mol Cell Cardiol. 1999 Nov;31(11):2063-76.

PMID:
10591032
46.

Desmin cytoskeleton in muscle integrity and function.

Capetanaki Y, Milner DJ.

Subcell Biochem. 1998;31:463-95. Review. No abstract available.

PMID:
9932503
47.

Desmin in muscle formation and maintenance: knockouts and consequences.

Capetanaki Y, Milner DJ, Weitzer G.

Cell Struct Funct. 1997 Feb;22(1):103-16. Review.

48.

Disruption of muscle architecture and myocardial degeneration in mice lacking desmin.

Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y.

J Cell Biol. 1996 Sep;134(5):1255-70.

49.
50.

Supplemental Content

Loading ...
Support Center